OTHERS OB HOLDINGS BERHAD ("OB HOLDINGS" OR "THE COMPANY") - LETTERS OF INTENT ENTERED INTO BY ORIENT BIOTECH SDN. BHD., A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY, WITH CSPC INNOVATION PHARMACEUTICAL CO., LTD. AND CSPC WEISHENG PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD., BOTH SUBSIDIARIES OF CSPC PHARMACEUTICAL GROUP LIMITED
| OB HOLDINGS BERHAD |
| Type | Announcement |
| Subject | OTHERS |
| Description | OB HOLDINGS BERHAD ("OB HOLDINGS" OR "THE COMPANY")
- LETTERS OF INTENT ENTERED INTO BY ORIENT BIOTECH SDN. BHD., A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY, WITH CSPC INNOVATION PHARMACEUTICAL CO., LTD. AND CSPC WEISHENG PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD., BOTH SUBSIDIARIES OF CSPC PHARMACEUTICAL GROUP LIMITED |
The Board of Directors of OB Holdings wishes to announce that, Orient Biotech Sdn. Bhd., a wholly-owned subsidiary of the Company had on 2 May 2025 entered into two (2) separate Letters of Intent, with CSPC Innovation Pharmaceutical Co., Ltd. and CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., both subsidiaries of CSPC Pharmaceutical Group Limited. Please refer to the attachment for the details of this announcement. This announcement is dated 2 May 2025. |
|
Please refer attachment below.
Announcement Info
| Company Name | OB HOLDINGS BERHAD |
| Stock Name | OBHB |
| Date Announced | 02 May 2025 |
| Category | General Announcement for PLC |
| Reference Number | GA1-02052025-00041 |